You are here: Industry Insights > NHS

News List

Mixed reaction to chancellor's spending review pharmatimes
November 27, 2020
Chancellor Rishi Sunak has unveiled the government's spending plans for the coming year, outlining funding plans for the NHS, clinical research and research and development.
COVID-19 pandemic has emphasised existing health inequalities, research finds pharmatimes
November 25, 2020
Research conducted by Imperial College London in partnership with Philips UK has found that the COVID-19 pandemic has highlighted existing healthcare inequalities in the UK.
Spending boost ‘welcome’ but more funding needed, says NHS Confed chief exec pharmatimes
November 24, 2020
The NHS Confederation’s chief executive Danny Mortimer has welcomed the extra £3bn investment for the NHS announced by the government, adding that ‘additional funding’ is needed.
NHS launches 40 ‘long COVID’ clinics pharmatimes
November 17, 2020
The NHS is rolling out a network of more than 40 long COVID specialist clinics in the next few weeks to help thousands of patients who are suffering debilitating effects of coronavirus months after infection.
NIHR establishes new patient recruitment research centres pharmatimes
November 16, 2020
The National Institute for Health Research (NIHR) has launched five national patient recruitment centres (NPRCs) to accelerate and aid life sciences companies to deliver late-stage clinical research within the NHS.
Waylivra, Tecentriq and more accepted by SMC pharmatimes
November 11, 2020
The Scottish Medicines Consortium has published guidance on eight new medicines, accepting seven of those and rejecting one for use by NHS Scotland in its November meeting.
NICE rules nivolumab is not cost effective for use on NHS europeanpharmaceuticalreview
November 10, 2020
The regulatory body said that due to uncertainties surrounding the long-term effectiveness of nivolumab (Opdivo), its cost-effectiveness estimates are too high.
New pricing models could improve access to innovative cancer drugs pharmatimes
November 10, 2020
A consensus panel has concluded that the NHS could improve patient access to new cancer drugs by varying the price it pays for different medicines depending on what disease they are used to treat.
NHS at a 'critical point' as COVID-19 cases climb pharmatimes
November 06, 2020
NHS Confederation chief executive Danny Mortimer has called for the public’s support to ensure that non-COVID services remain open by following ‘national guidance’.
Sensyne Health signs new NHS research agreement pharmatimes
October 29, 2020
Clinical AI company Sensyne Health has signed a five-year strategic research agreement (SRA) with Milton Keynes University Hospital Foundation Trust (MKUH).

Previous page 1 2 3 4 5 6 7 8 9 10 ... 44 45 Next page